piroxantrone has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eisenhauer, EA | 1 |
Anderson, T; Chang, AY; Glick, J; Johnson, D; Karp, D; Kim, K | 1 |
Crowley, JJ; Doroshow, JH; Hantel, A; Livingston, R; Williamson, SK | 1 |
2 trial(s) available for piroxantrone and Lung Neoplasms
Article | Year |
---|---|
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
Topics: Adult; Aged; Aged, 80 and over; Anthraquinones; Antineoplastic Agents; Atrial Fibrillation; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pyrazoles; Remission Induction; Survival Analysis; Thiobarbiturates | 1993 |
Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pyrazoles | 1992 |
1 other study(ies) available for piroxantrone and Lung Neoplasms
Article | Year |
---|---|
Taxol in advanced non-small-cell lung cancer: plus Ca change?
Topics: Anthraquinones; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Humans; Lung Neoplasms; Paclitaxel; Pyrazoles; Thiobarbiturates | 1993 |